Also, the data presented warrants a better understanding of CBX2/7 biology and invite further research into how these readers of same histone code (trimethylation of lysine residue of H3) differentially alter metabolic reprogramming in breast cancer. The gene discussed is CBX2; the disease is breast carcinoma.